| HSF2 | |
|---|---|
| Full Name | Heat Shock Transcription Factor 2 |
| Location | Chr 6q22.31 |
| NCBI Gene ID | 3298 |
| OMIM | 140581 |
| Ensembl | ENSG00000125124 |
| UniProt | Q03934 |
| Associated Diseases | Neurodegeneration, Developmental disorders |
HSF2 (Heat Shock Transcription Factor 2) is a member of the heat shock factor (HSF) family of transcription factors that regulate the expression of heat shock proteins (HSPs) and other cytoprotective genes[1]. While HSF1 is the primary stress-responsive HSF, HSF2 plays crucial roles in developmental processes, brain development, and maintenance of proteostasis in neurons[2]. HSF2 functions as a trimeric transcription factor that binds to heat shock elements (HSEs) in target gene promoters.
The HSF2 gene spans approximately 25 kb on chromosome 6q22.31 and contains 13 exons. The encoded protein contains several functional domains:
HSF2 exists in two major isoforms generated by alternative splicing: HSF2-α (full-length) and HSF2-β (shorter, lacking part of the regulatory domain)[3].
HSF2 regulates the expression of classical heat shock proteins including:
HSF2 is essential for brain development and neuronal differentiation. HSF2 knockout mice exhibit:
HSF2 regulates genes involved in neuronal migration and cortical patterning, working in concert with HSF1 during stress responses[6].
In mature neurons, HSF2 contributes to:
HSF2 dysfunction has been implicated in several neurodegenerative conditions:
Alzheimer's Disease: Reduced HSF2 expression correlates with impaired chaperone induction and accumulation of protein aggregates[8]. The HSF2 pathway represents a therapeutic target for enhancing proteostasis in AD.
Parkinson's Disease: HSF2 regulates expression of chaperones that prevent α-synuclein aggregation. Impaired HSF2 activity may contribute to Lewy body formation[9].
Huntington's Disease: HSF2 cooperates with HSF1 in inducing chaperones that suppress polyglutamine aggregation in huntingtin protein[10].
Mutations affecting HSF2 function are associated with:
HSF2 is expressed ubiquitously but shows elevated expression in:
Expression data from the Allen Brain Atlas shows prominent HSF2 expression in cortical neurons and hippocampal pyramidal cells[11].
| Variant | rsID | Effect | Significance |
|---|---|---|---|
| rs2254391 | Intergenic | Gene expression | GWAS signal |
| rs6942713 | Promoter | Transcriptional regulation | eQTL |
Several approaches are being explored to enhance HSF2 activity:
HSF2 activation may synergize with:
Åkerfelt M, Morimoto RI, Sistonen L. Heat shock factors: integrators of cell stress, development and lifespan. Nature Reviews Molecular Cell Biology. 2010. ↩︎
El Fatimy R, et al. Heat shock factor 2: A novel player in the heat shock response and neurodegenerative diseases. Journal of Neuroscience. 2014. ↩︎
Goodson ML, Sarge KD. Regulated expression of heat shock factor 2. Journal of Biological Chemistry. 1995. ↩︎
Fujimoto M, Nakai M. The heat shock factor family and adaptation to proteotoxic stress. FEBS Journal. 2010. ↩︎
Kallio M, et al. Brain abnormalities, defective meiotic chromosome synapsis and female subfertility in HSF2 null mice. EMBO Journal. 2002. ↩︎
Chang Y, et al. Role of heat shock factor 2 in cerebral cortex formation and neurogenesis. Molecular and Cellular Biology. 2006. ↩︎
Gomez-Pastor R, Burchfiel ET, Thiele DJ. Regulation of heat shock transcription factors and their roles in physiology and disease. Nature Reviews Molecular Cell Biology. 2018. ↩︎
Hooper PL, et al. Central role of HSF1 in neuroprotection and neurodegeneration. Cell Stress and Chaperones. 2016. ↩︎
Kourtis N, Tavernarakis N. Heat shock proteins and neurodegeneration. Current Topics in Medicinal Chemistry. 2011. ↩︎
Hayashida N, et al. Heat shock factor 1 and heat shock factor 2 play distinct roles in polyglutamine aggregation and neurodegeneration. Journal of Biological Chemistry. 2019. ↩︎
Hawrylycz MJ, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012. ↩︎
Neef DW, Jaeger AM, Thiele DJ. Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nature Reviews Drug Discovery. 2011. ↩︎